Last reviewed · How we verify
NCT06027762: FeetMe-GRF
Assessment of vGRF Measurement During Walking With Feetme® Insoles in Healthy Adults
trial in Healthy Volunteers in 37 participants. Completed in 30 November 2022.
30 November 2022
Quick facts
| Lead sponsor | FeetMe |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 37 |
| Start date | 1 February 2022 |
| Primary completion | 30 November 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across France |
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
FeetMe
Who can join
Adults 18 to 80, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the present study is to demonstrate the validity and reliability of vGRF and other gait parameters measurement in healthy adults while walking with FeetMe® insoles compared to force plates (AMTI BP400600) and video motion capture system (Vicon NEXUS and MX-T40) .
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of feetme insoles with a motion capture system coupled to force plates for assessing gait and posture.
Huang P, Mostovov A, Cohen R, Cadilhac C, et al · · 2025 · PMID 40251254 · DOI 10.1038/s41598-025-96878-8
Verify or expand the search:
- PubMed search for NCT06027762
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other FeetMe trials
Trials by the same sponsor.
- NCT05536687 — VALIDITY AND RELIABILITY OF THE 6-MINUTES WALKING TEST EVALUATED BY FEETME® INSOLES · NA · terminated
- NCT05155761 — Identifying Risk Factors for Falls in Patients With a High Risk of Fracture Using Connected Insoles (FeetMe Monitor® Dev · NA · unknown
- NCT04266743 — FeetMe® Monitor: Alternative for the Evaluation of Gait Speed After Stroke · NA · completed
- NCT04268017 — Validation Study : FeetMe® Monitor Insoles for the Evaluation of Gait Speed · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06027762 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FeetMe
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06027762.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing